Media, PA Office

610-892-9070

Philadelphia, PA Office

215-546-8200

Westmont, NJ Office

856-427-9100
  • Blog >
  • Major prognostic and treatment advances are made against a rare and deadly disease.

Major prognostic and treatment advances are made against a rare and deadly disease.

Excerpted from the National Cancer Institute, Center for Cancer Research (CCR)

Two Strikes Against Mesothelioma

In one study, CCR researchers identified gene signatures that are associated with mesothelioma prognosis and can help determine a patient’s response to therapy. In a second study, CCR researchers showed that it was possible to treat mesothelioma with adoptive T-cell therapy. These two strikes against mesothelioma, one from basic research, one from a clinical trial, will help fight this rare cancer. Credit: iStock

Mesothelioma, an aggressive tumor that affects the lining of the lungs or abdomen, belongs to the unfortunate list of cancers that are aggressive, difficult to treat and have poor outcomes. But a combination of lab and clinical work in CCR now holds promise for a cancer that has been intractable for many years.

Read the article: https://ccr.cancer.gov/news/milestones-2024/two-strikes-against-mesothelioma

Contact the Asbestos Lawyers at Nass Cancelliere Today

If you or a loved one has been diagnosed with mesothelioma as a result of exposure to asbestos, contact the experienced attorneys at Nass Cancelliere. For more than 40 years, the Philadelphia-based law firm of NASS CANCELLIERE has represented 4,500 people who have contracted MESOTHELIOMA and other forms of asbestos-related illness. Our attorneys have tried over 1,000 cases throughout Pennsylvania and New Jersey and we have collected over $500 million for our clients. Learn more by calling 215-546-8200 to speak with an attorney or contacting us online.

Contact the Firm

Please fill out the form below and one of our attorneys will contact you.

!
!
!

Our Locations